Involvement of endocrine system in a patient affected by Glycogen storage disease 1b: Speculation on the role of autoimmunity

Italian Journal of Pediatrics

Volumn 40, Issue 1, 2014, Pages

  Melis, Daniela ^a   Casa, Roberto Della ^a   Balivo, Francesca ^a   Minopoli, Giorgia ^a   Rossi, Alessandro ^a   Salerno, Mariacarolina ^a   Andria, Generoso ^a   Parenti, Giancarlo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Autoimmunity; Glycogen storage disease 1b; Growth hormone deficiency; Inflammatory bowel disease; Thyroiditis

Indexed keywords

ANTIBIOTIC AGENT; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CHOLINERGIC RECEPTOR ANTIBODY; COMPLEMENT COMPONENT C1Q ANTIBODY; COMPLEMENT COMPONENT C3D ANTIBODY; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOUBLE STRANDED DNA ANTIBODY; GLUCOSE 6 PHOSPHATASE; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH HORMONE; HYDROCORTISONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PHOSPHOLIPID ANTIBODY; SOMATOMEDIN C; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROTROPIN; UNCLASSIFIED DRUG;

ADOLESCENT; APHTHOUS STOMATITIS; ARTICLE; AUTOIMMUNE THYROIDITIS; BLOOD GROUP ABO INCOMPATIBILITY; CANDIDIASIS; CASE REPORT; CHRONIC INFLAMMATION; DIET THERAPY; DYSLIPIDEMIA; ECHOGRAPHY; ELEMENTAL DIET; FOLLOW UP; GASTROINTESTINAL INFECTION; GENE MUTATION; GLYCOGEN STORAGE DISEASE TYPE 1; GLYCOGEN STORAGE DISEASE TYPE 1B; GROWTH HORMONE DEFICIENCY; HEMOLYTIC ANEMIA; HEPATOMEGALY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; HYPERBILIRUBINEMIA; HYPERURICEMIA; HYPOGLYCEMIA; ILEUM DISEASE; KIDNEY DISEASE; LACTIC ACIDOSIS; MALE; MICROALBUMINURIA; MOLECULAR DIAGNOSIS; MUTATIONAL ANALYSIS; NEUTROPENIA; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; RECURRENT INFECTION; RESPIRATORY TRACT INFECTION; SEIZURE; SHORT STATURE; SKIN PIGMENTATION; SPLENOMEGALY; SUBCLINICAL HYPOTHYROIDISM; ULCER;

AUTOIMMUNITY; DISEASE PROGRESSION; ENDOCRINE SYSTEM; FOLLOW-UP STUDIES; GLYCOGEN STORAGE DISEASE TYPE I; HUMANS; INFANT; MALE; TIME FACTORS;

EID: 84898009085     PISSN: 17208424     EISSN: 18247288     Source Type: Journal    
DOI: 10.1186/1824-7288-40-30     Document Type: Article

References (20)

1. Glycogen storage disease. Chen YT, The Metabolic and Molecular Bases of Inherited Disease New York: McGraw-Hill, Scriver CR, Beaudet AL, Valle D, Sly WS, Kinzler V, 8 2001 1521 1551
2. Mutations in the glucose-6-phosphatase gene are associated with glycogen storage disease types 1a and 1aSP but not 1b and 1c. Lei KJ, Shelly LL, Lin B, Sidbury JB, Chen YT, Nordlie RC, J Clin Investig 1995 95 234 240 10.1172/JCI117645 7814621
3. Mutations in the glucose-6-phosphate transporter (G6PT) gene in patients with glycogen storage diseases type 1b and 1c. Galli L, Orrico A, Marcolongo P, Fulceri R, Burchell A, Melis D, Parini R, Gatti R, Lam C-W, Benedetti A, Sorrentino V, FEBS Lett 1999 459 255 258 10.1016/S0014-5793(99)01248-X 10518030
4. Crohn's-like ileo-colitis in patients affected by glycogen storage disease Ib: two years' follow-up of patients with a wide spectrum of gastrointestinal signs. Melis D, Parenti G, Della Casa R, Sibilio M, Berni Canani R, Terrin G, Cucchiara S, Andria G, Acta Paediatr 2003 92 1415 1421 10.1080/08035250310007033 14971792
5. Genotype/phenotype correlation in glycogen storage disease type 1b: a multicentre study and review of the literature. Melis D, Fulceri R, Parenti G, Marcolongo P, Gatti R, Parini R, Riva E, Della Casa R, Zammarchi E, Andria G, Benedetti A, Eur J Pediatr 2005 164 501 508 10.1007/s00431-005-1657-4 15906092
6. Vitamin E supplementation improves neutropenia and reduces the frequency of infections in patients with glycogen storage disease type 1b. Melis D, Della Casa R, Parini R, Rigoldi M, Cacciapuoti C, Marcolongo P, Benedetti A, Gaudieri V, Andria G, Parenti G, Eur J Pediatr 2009 168 1069 1074 10.1007/s00431-008- 0889-5 19066956
7. Consensus guidelines for management of glycogen storage disease type 1b-European Study on Glycogen Storage Disease Type 1. Visser G, Rake JP, Labrune P, Leonard JV, Moses S, Ullrich K, Wendel U, Smit GP, Eur J Pediatr 2002 168 Suppl 1 120 S123
8. Neutrophils in the pathogenesis and manifestations of SLE. Kaplan MJ, Nat Rev Rheumatol 2011 7 691 699 10.1038/nrrheum.2011.132 21947176
9. Autoimmunity in Wiskott-Aldrich syndrome: an unsolved enigma. Catucci M, Castiello MC, Pala F, Bosticardo M, Villa A, Front Immunol 2012 3 209 22826711
10. Increased prevalence of thyroid autoimmunity and hypothyroidism in patients with glycogen storage disease type I. Melis D, Pivonello R, Parenti G, Della Casa R, Salerno M, Lombardi G, Sebastio G, Colao A, Andria G, J Pediatr 2007 150 300 305 10.1016/j.jpeds.2006.11.056 17307551
11. The growth hormone-insulin-like growth factor axis in glycogen storage disease type 1: evidence of different growth patterns and insulin-like growth factor levels in patients with glycogen storage disease type 1a and 1b. Melis D, Pivonello R, Parenti G, Della Casa R, Salerno M, Balivo F, Piccolo P, Di Somma C, Colao A, Andria G, J Pediatr 2010 156 663 670 10.1016/j.jpeds.2009.10.032 20022338
12. Myasthenia gravis in a patient affected by glycogen storage disease type Ib: a further manifestation of an increased risk for autoimmune disorders? Melis D, Balivo F, Della Casa R, Romano A, Taurisano R, Capaldo B, Riccardi G, Monsurrò MR, Parenti G, Andria G, J Inherit Metab Dis 2008 31 Suppl 2 227 S231 18437526
13. Autoimmunity as a possible cause of growth hormone deficiency. De Bellis A, Colao A, Tirelli G, Ruocco G, Di Somma C, Battaglia M, Pane E, Bellastella G, Dello Iacovo A, Sinisi AA, Bizzarro A, Bellastella A, J Endocrinol Invest 2008 31 1132 1134 10.1007/BF03345664 19246982
14. The natural history of the normal/mild elevated TSH serum levels in children and adolescents with Hashimoto's thyroiditis and isolated hyperthyrotropinaemia: a 3-year follow-up. Radetti G, Maselli M, Buzi F, Corrias A, Mussa A, Cambiaso P, Salerno M, Cappa M, Baiocchi M, Gastaldi R, Minerba L, Loche S, Clin Endocrinol (Oxf) 2012 76 394 398 10.1111/j.1365-2265.2011.04251.x 21981142
15. Prospective evaluation of the natural course of idiopathic subclinical hypothyroidism in childhood and adolescence. Wasniewska M, Salerno M, Cassio A, Corrias A, Aversa T, Zirilli G, Capalbo D, Bal M, Mussa A, De Luca F, Eur J Endocrinol 2009 160 417 421 10.1530/EJE-08-0625 19074464
16. The association between immunodeficiency and the development of autoimmune disease. Sleasman JW, Adv Dent Res 1996 10 57 61 10.1177/ 08959374960100011101 8934926
17. Long-term monitoring of insulin sensitivity in growth hormone-deficient adults on substitutive recombinant human growth hormone therapy. Giavoli C, Porretti S, Ronchi CL, Cappiello V, Ferrante E, Orsi E, Arosio M, Beck-Peccoz P, Metabolism 2004 53 740 743 10.1016/j.metabol.2003.11.025 15164321
18. Effects of growth hormone on glucose metabolism. Møller N, Jørgensen JO, Abildgård N, Orskov L, Schmitz O, Christiansen JS, Horm Res 1991 36 Suppl 1 32 35
19. Hepatic adenoma associated with recombinant human growth hormone therapy in a patient with Turner's syndrome. Espat J, Chamberlain RS, Sklar C, Blumgart LH, Dig Surg 2000 17 640 643 10.1159/000051977 11155014
20. Quality of life in adult patients with glycogen storage disease type I: results of a multicenter Italian study. Sechi A, Deroma L, Paci S, Lapolla A, Carubbi F, Burlina A, Rigoldi M, Di Rocco M, JIMD Rep 2013 [Epub ahead of print]